Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Appili Therapeutics Inc. (APLIF) had Free Cash Flow per Share of $-0.00 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.09M |
|
$-1.23M |
|
-- |
|
$0.09M |
|
$1.25M |
|
$-1.17M |
|
$-0.06M |
|
$-1.22M |
|
$-1.22M |
|
$-1.23M |
|
$-1.23M |
|
$-1.23M |
|
$-1.23M |
|
$-1.17M |
|
$-1.16M |
|
132.37M |
|
132.37M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.93M |
|
$0.01M |
|
$0.01M |
|
$0.94M |
|
$14.21M |
|
$0.46M |
|
$0.46M |
|
$14.68M |
|
$-13.74M |
|
$-13.74M |
|
$-13.74M |
|
132.37M |
|
| Cash Flow Statement Financials | |
$-0.03M |
|
-- |
|
$0.12M |
|
$0.03M |
|
$0.10M |
|
$0.07M |
|
$0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.07 |
|
-- |
|
-- |
|
-0.03 |
|
-0.70 |
|
100.00% |
|
-1368.87% |
|
-1368.87% |
|
-- |
|
-1435.44% |
|
-1441.52% |
|
$-0.03M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
0.12 |
|
730.46 |
|
8.93% |
|
8.93% |
|
-131.21% |
|
9.24% |
|
$-0.10 |
|
|
Free Cash Flow per Share |
$-0.00 |
$-0.00 |
|